Clinical Trial Update: Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating delivery of LysoLox inhibitors on serial angioplasty and time to restenosis for arteriovenous fistula occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula Occlusion

Drugs mentioned

• LysoLox inhibitors

Snippet

Sponsor: Southeast Renal Research Institute | Conditions: Arteriovenous Fistula Occlusion | Phase 2 | Status: UNKNOWN